Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Gareth Chaney/Photocall Ireland
Christy Dignam

Aslan's Christy Dignam diagnosed with cancer

The band have asked for support from fans and for privacy for Dignam, his wife, Kathryn and daugher, Kiera.

ASLAN’S LEAD SINGER, Christy Dignam, has been diagnosed with cancer.

A statement on the band’s Facebook page confirmed the news today.

It was initially believed that Dignam had a chest infection, which progressed to pneumonia but it was later discovered it was cancer.

The band have asked for support from fans and for privacy for Dignam, his wife, Kathryn and daugher, Kiera.

The statement read:

Christy was admitted to hospital last week with a suspected chest infection,this progressed into pneumonia. After numerous tests being carried out he has been diagnosed with cancer,he is to undergo treatment immediately and will be unable to perform until he is feeling better and doctors advise it is safe to do so. We would like to thank everyone for their well wishes and messages,we are trying to deal with this news and help him through his illness and hope fans will continue to be as supportive as they have always been. We would like to ask for some privacy at this time thank you Kathryn and Kiera Dignam and all the members and crew of Aslan.

The group are said to be cancelling some up-and-coming gigs, including the one scheduled for St. Patrick’s Day in The Olympia, Dublin.

Your Voice
Readers Comments
77
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.